RAMHX
Price
$35.96
Change
-$0.05 (-0.14%)
Updated
Jun 25 closing price
Net Assets
248.02B
SIBLX
Price
$28.68
Change
-$0.02 (-0.07%)
Updated
Jun 25 closing price
Net Assets
951.79M
Interact to see
Advertisement

RAMHX vs SIBLX

Header iconRAMHX vs SIBLX Comparison
Open Charts RAMHX vs SIBLXBanner chart's image
American Funds American Balanced R2E
Price$35.96
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets248.02B
Touchstone Balanced Y
Price$28.68
Change-$0.02 (-0.07%)
VolumeN/A
Net Assets951.79M
RAMHX vs SIBLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RAMHX vs. SIBLX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAMHX is a Buy and SIBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 248B vs. SIBLX (952M). SIBLX pays higher dividends than RAMHX: SIBLX (1.62) vs RAMHX (1.49). RAMHX was incepted earlier than SIBLX: RAMHX (11 years) vs SIBLX (18 years). RAMHX (1.04) is less costly to investors than SIBLX (0.79). SIBLX is a more actively managed with annual turnover of: 70.00 vs. RAMHX (44.00). RAMHX has a lower initial minimum investment than SIBLX: RAMHX (250) vs SIBLX (2500). SIBLX annual gain was more profitable for investors over the last year : 9.82 vs. RAMHX (6.10). SIBLX return over 5 years is better than : 40.93 vs. RAMHX (37.49).
RAMHXSIBLXRAMHX / SIBLX
Total Expense Ratio1.040.79132%
Annual Report Gross Expense Ratio1.040.79132%
Fund Existence11 years18 years-
Gain YTD5.8614.234138%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets248B952M26,050%
Annual Yield % from dividends1.491.6292%
Returns for 1 year6.109.8262%
Returns for 3 years30.2536.6483%
Returns for 5 years37.4940.9392%
Returns for 10 years56.2365.3986%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YMAB5.130.41
+8.69%
Y-mAbs Therapeutics
EKSO3.060.24
+8.51%
Ekso Bionics Holdings Inc
VRT122.325.78
+4.96%
Vertiv Holdings Co
NTLA9.570.34
+3.68%
Intellia Therapeutics
HWC56.140.78
+1.41%
Hancock Whitney Corp